Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Key market opportunities for the e-commerce BNPL sector include expanding into emerging markets, leveraging partnerships with fintech, focusing on responsi...
Justin Trudeau has forked over $3.1 million for an expansive estate in Montreal's exclusive Outremont neighborhood-and got the seal of approval from girlfr...
Singapore based BTC and AI miner sells all holdings to build liquidity for expansion, signaling a broader shift in capital strategy across the sector.
The home, inspired by Kubrick's 2001 movie "Space Odyssey" is located in a highly sought-after neighborhood of Hollywood Hills, but has been on the market...
Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.
Novo Nordisk shares plunge after obesity drug falls short of rival in trial
This ETF invests aggressively in high-growth stocks, while maintaining minimal exposure to worse-performing areas of the market.
The financing forms part of a wider $1.75bn funding package authorised by US Bankruptcy Judge Alfredo Perez during a hearing in Houston.
Johnson Matthey shares sink 15% as Honeywell trims deal to GBP1.33 bln
GeminiâEUR(TM)s Tyler Winklevoss said heâEUR(TM)s âEUR?"optimisticâEUR amid peak crypto pessimism, but SEC filings, layoffs and public data on Winklevoss...
CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of showing non-inferiority on weight l...